Compound index — A

1,493 substances begin with A. 5 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, A carbohydrate:protein… – Acmella Oleracea….

Search the whole index — 15,651 substances

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance

A carbohydrate:protein (CHO:P) ratio ≤ 1.8 on an energy basis in the context of an energy-restricted diet and body weight EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Helps to achieve a reduction in body weight and body fat when consumed as part of an energy restricted diet (< 8,368 kJ/2,000 kcal/day) for a minimum of 12 weeks.”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-013603

A combination of artichoke leaf dry extract standardised in caffeoylquinic acids, monacolin K in red yeast rice, sugar-cane derived policosanols, procyanidolic oligomers from French maritime pine bark, garlic dry extract standardised in allicin, d-α-tocopheryl hydrogen succinate, riboflavin and inositol hexanicotinate EU-CLAIM Not yet graded

EU claims 1 authorised / 0 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“A combination of artichoke leaf dry extract standardised in caffeoylquinic acids, monacolin K in red yeast rice, sugar-cane derived policosanols, procyanidolic oligomers from French maritime pine bark, garlic dry extract standardised in allicin, d-α-tocopheryl hydrogen succinate, riboflavin and inositol hexanicotinate reduces blood LDL-cholesterol concentrations. High LDL-cholesterol is a risk factor in the…”	Authorised	Art.14(1)(a)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000620

A combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104 EU-CLAIM Not yet graded

EU claims 0 authorised / 2 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Improves intestinal discomfort”	Non-authorised	Art.13(5)	EFSA opinion
“Regulates your (intestinal) transit”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000621

A combination of beta-sitosterol and beta-sitosterol glucoside EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Contributes to the normal function of the immune system by restoring balance between TH1- and TH2- mediated immunity”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-013601

A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Regulates your (intestinal) transit.”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000623

A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Improve intestinal discomfort”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000624

A combination of diosmin, troxerutin and hesperidin EU-CLAIM Not yet graded

EU claims 0 authorised / 2 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“The flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous tone”	Non-authorised	Art.13(5)	EFSA opinion
“The flavonoid mixture containing 300 mg of diosmin, 300 mg of troxerutin and 100 mg of hesperidin is a useful co adjuvant in maintaining physiological venous-capillary permeability”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000622

A combination of flaxseed oil and vitamin E EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Contributes to maintain skin permeability barrier function”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000626

A combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Contributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal.”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-010733

A combination of lutein and zeaxanthin EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Lutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions.”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000627

A combination of lycopene, vitamin E, lutein and selenium EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Helps to prepare sensitive skin from the inside to improve their tolerance to the sun”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000628

A combination of Paullinia cupana Kunth (guarana) and Camellia sinensis (L.) Kuntze (green tea) extracts EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Helps to burn fat”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000625

A combination of pomegranate pomace extract and greater galangal rhizome powder EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“A combination of standardised pomegranate pomace extract and greater galangal rhizome powder increases the number of motile spermatozoa in semen.”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000629

A combination of red spinach, green spinach, red chicory, green chicory, green leaf chard, red leaf chard, red Swiss chard, golden Swiss chard and white Swiss chard EU-CLAIM Not yet graded

EU claims 0 authorised / 2 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Contributes to the protection of blood lipids from oxidative damage”	Non-authorised	Art.13(5)	EFSA opinion
“Maintain normal blood cholesterol concentrations”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000630

A combination of the probiotics: Lactobacillus casei F19, Lactobacillus plantarum 2592, Leuconostoc mesenteroides 77:1, Pediococcus pentosaceus 16:1 EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Support your natural defence. Helps your body's natural defence. Supports the immune system. Contains the probiotics Lactobacillus casei F19, Lactobacillus plantarum 2592, Leuconostoc mesenteroides 77:1, Pediococcus pentosaceus 16:1”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000631

A combination of thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, D-biotin and pumpkin seed oil (Cucurbita pepo L.) EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Helps to increase hair number”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000632

A combination of three probiotic ingredients; Lactobacillus casei F19, Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5 EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Balances the gut flora. Helps to restore an unbalanced gut flora. Supports a healthy gut flora. Supports a healthy gut flora during antibiotic treatment Supports a healthy gut flora during temporary disturbances eg. stress and antibiotic treatment”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000633

A combination of three probiotic ingredients; Lactobacillus casei F19, Bifidobacterium lactis Bb12, Lactobacillus acidophilus La5 EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Helps your natural bowel regularity Helps to regulate your intestinal flora”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000634

A combination of three probiotic strains: -Lactobacillus gasseri 57C -Lactobacillus fermentum 57A -Lactobacillus plantarum 57B Trade name of the food supplement: prOVag EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Provag contributes to re-balance the physiological bacterial flora and to maintain a proper vaginal pH. Provag shows an antagonistic effect on the most common pathogenic bacteria and fungi in the urogenital system Oral probiotics of a vaginal effect are used during and after taking antibacterial, antitrichomonal and antimycotic antibiotics. Provag contains living lactobacilli, which due to their strong probiotic…”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000635

A combination of Tuscan black cabbage, 'tri-coloured‘ Swiss chard, 'bi-coloured‘ spinach and 'blu savoy‘ cabbage EU-CLAIM Not yet graded

EU claims 0 authorised / 2 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Contributes to the protection of blood lipids from oxidative damage”	Non-authorised	Art.13(5)	EFSA opinion
“Maintains normal blood cholesterol concentration”	Non-authorised	Art.13(5)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000636

A Turkey 14/98 ≥ 6 PD50* EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedQI02AA04

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000647

a-Lactalbumin EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“a-Lactalbumin increases cognitive function”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000652

A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000618

A/California/07/2009 (H1N1)pdm09-like strain (A/California/07/2009) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000619

A/Darwin/1415/2025 (H3N2)-like strain (A/Tasmania/787/2025, CVR-388) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000637

A/Darwin/1454/2025 (H3N2) - like strain (A/Darwin/1369/2025, MEDI 406666) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB03

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000638

A/Darwin/1454/2025 (H3N2)-like strain (A/Michigan/105/2025, IVR-285) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000639

A/Darwin/9/2021 (H3N2) - like strain (A/Norway/16606/2021, MEDI 355293) / A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/1/2020, MEDI 340505) / B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, MEDI 355292) / B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, MEDI 306444) EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedJ07BB03

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000640

A/equine-2/Newmarket/2/93 EU-MED Not yet graded

EU medicine: Authorised

Market presence2 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000641

A/H3N2 EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07B

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000642

A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2) EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000643

A/Missouri/11/2025 (H1N1)pdm09 - like strain (A/Switzerland/6849/2025, MEDI 400592) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB03

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000644

A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Missouri/11/2025, IVR-279) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000645

A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012) EU-MED Not yet graded

EU medicine: Authorised

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000646

A/Victoria/361/2011 (H3N2) like strain EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedJ07BB03

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000648

A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) / A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022 IVR-237) / B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) / B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, BVR-1B) influenza virus EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000649

A/VietNam/1194/2004 EU-MED Not yet graded

EU medicine: Application withdrawn

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000650

A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022, CVR-167) A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type) B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type) EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedJ07BB02

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000651

A22 Iraq ≥ 6 PD50* EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedQI02AA04

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000653

A24 Cruzeiro ≥ 6 PD50* EU-MED Not yet graded

EU medicine: Withdrawn

Class as recordedQI02AA04

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000654

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) US-CSA Not yet graded

CSA Schedule I

also: AB-CHMINACA -1- -1H-indazole-3-carboxamide)

Class as recordedDEA: hallucinogen / synthetic cannabinoid

DEA other namesAB-CHMINACA

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000655

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) US-CSA Not yet graded

CSA Schedule I

also: AB-FUBINACA -1- -1H-indazole-3-carboxamide)

Class as recordedDEA: hallucinogen / synthetic cannabinoid

DEA other namesAB-FUBINACA

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000656

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) US-CSA Not yet graded

CSA Schedule I

also: AB-PINACA -1-pentyl-1H-indazole-3-carboxamide)

Class as recordedDEA: hallucinogen / synthetic cannabinoid

DEA other namesAB-PINACA

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000657

Abacavir EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: anda

Class as recordedCytochrome P450 1A1 Inhibitors [MoA]; HIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]

Earliest US approval1998

Market presence44 US product listings · 43 FDA applications · 2 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000658

Abacavir, Dolutegravir, Lamivudine US-DRUG Not yet graded

Earliest US approval2024

Market presence4 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000659

Abaloparatide EU-MEDUS-DRUG Not yet graded

EU medicine: Authorised, RefusedUS: bulk ingredient

Class as recordedH05AA; H05AA04; Parathyroid Hormone-Related Peptide Analog [EPC]; Parathyroid Hormone-Related Protein [CS]

Earliest US approval2017

Market presence7 US product listings · 1 FDA applications · 1 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000660

Abametapir US-DRUG Not yet graded

Earliest US approval2020

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000661

Abarelix US-DRUG Not yet graded

Earliest US approval2003

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000662

Abatacept EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: bla

Class as recordedDecreased Cytokine Activity [PE]; L04AA24; Recombinant Fusion Proteins [CS]; Selective T Cell Costimulation Modulator [EPC]

Earliest US approval2005

Market presence6 US product listings · 1 FDA applications · 1 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000663

Abciximab US-DRUG Not yet graded

Earliest US approval1994

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000664

Abel Moschus CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000665

Abelmoschus CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000666

Abelmoschus esculentus CA-NHPEU-NOVEL Not yet graded

Not novel in foodCA licensed ingredient

also: Hibiscus esculentus L.

Market presence35 Canadian licensed products

Parts in scopeFruit

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000667

Abelmoschus manihot CA-NHP Not yet graded

CA licensed ingredient

Market presence5 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000668

Abelmoschus moschatus CA-NHP Not yet graded

CA licensed ingredient

Market presence7 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000669

Abelmoschus Moschatus Flower US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000670

Abelmoschus Moschatus Seed US-DRUG Not yet graded

US: unapproved homeopathic

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000671

Abemaciclib EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: bulk ingredient

Class as recordedKinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; L01EF03

Earliest US approval2017

Market presence16 US product listings · 3 FDA applications · 1 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000672

abetimus EU-MED Not yet graded

EU medicine: Application withdrawn

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000673

abicipar pegol EU-MED Not yet graded

EU medicine: Application withdrawn

Class as recordedS01LA

Market presence1 EU medicines

Recorded fromEU-MED — 1 of 7 registers

Etalyn identifierETA-C-000674

Abies alba CA-NHPEU-NOVEL Not yet graded

Not novel in supplementsCA licensed ingredient

also: Whitewood; Silver fir; Abies pectinata; Abies alba Mill.; European silver fir

Market presence33 Canadian licensed products

Parts in scopeExtracts of any of the following parts: bark, branch, needle, seed and resin

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000675

Abies Alba Leafy Twig US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations

Market presence3 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000676

Abies balsamea CA-NHPEU-NOVEL Not yet graded

Not novel in supplementsCA licensed ingredient

also: Balsam fir; Canadian balsam; Abies balsamea f. balsamea

Market presence99 Canadian licensed products

Parts in scopeLeaves and bark

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000677

Abies Balsamea Leaf Oil US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000678

Abies canadensis CA-NHP Not yet graded

CA licensed ingredient

Market presence18 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000679

Abies nigra CA-NHP Not yet graded

CA licensed ingredient

Market presence14 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000680

Abies sibirica CA-NHP Not yet graded

CA licensed ingredient

Market presence7 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000681

Abiraterone EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: anda

Class as recordedCytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Earliest US approval2011

Market presence74 US product listings · 18 FDA applications · 5 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000682

abobotulinumtoxinA US-DRUG Not yet graded

Earliest US approval2009

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000683

Abrocitinib EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: bulk ingredient

Class as recordedD11AH08; Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Earliest US approval2022

Market presence10 US product listings · 1 FDA applications · 1 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000684

Abroma augusta CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000685

Abroma augustum CA-NHP Not yet graded

CA licensed ingredient

Market presence6 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000686

Abroma Augustum Root US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000687

Abroma Augustum Whole US-DRUG Not yet graded

US: unapproved homeopathic

Market presence3 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000688

Abroma radix CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000689

Abrotanum CA-NHP Not yet graded

CA licensed ingredient

Market presence13 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000690

Abrus cantoniensis CA-NHP Not yet graded

CA licensed ingredient

Market presence30 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000691

Abrus precatorius CA-NHP Not yet graded

CA licensed ingredient

Market presence3 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000692

Abrus Precatorius Seed US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Animal Fur [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]

Market presence10 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000693

Absinthii herba EU-HERBUS-DRUG Not yet graded

Herbal monograph: C: ongoing call for scientific dataUS: drug for further processing

also: Wormwood; Artemisia absinthiumL.

Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Copper [CS]

Market presence63 US product listings

Recorded fromEU-HERB, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000694

Absinthium CA-NHP Not yet graded

CA licensed ingredient

Market presence14 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000695

Abutilon indicum CA-NHP Not yet graded

CA licensed ingredient

Market presence6 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000696

Abutilon Theophrasti Seed US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000697

Acacia CA-NHPUS-DRUG Not yet graded

CA licensed ingredientUS: bla

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]

Market presence8 US product listings · 152 Canadian licensed products

Recorded fromCA-NHP, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000698

Acacia catechu CA-NHP Not yet graded

CA licensed ingredient

Market presence16 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000699

Acacia Dealbata Pollen US-DRUG Not yet graded

US: bla

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence12 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000700

Acacia gum (gum arabic) EU-CLAIM Not yet graded

EU claims 0 authorised / 9 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“- gum acacia helps to reduce blood cholesterol; - gum acacia contribute to maintain a good cardiovascular health; - gum acacia helps to control blood cholesterol level.”	Non-authorised	Art.13(1)	EFSA opinion
“-acacia gum promotes good intestinal health;-acacia gum improves bowel functions & gut comfort;”	Non-authorised	Art.13(1)	EFSA opinion
“-acacia gum promotes good intestinal health;-acacia gum improves bowel functions & gut comfort;”	Non-authorised	Art.13(1)	EFSA opinion
“-acacia gum promotes good intestinal health;-acacia gum improves bowel functions & gut comfort;”	Non-authorised	Art.13(1)	EFSA opinion
“Gum acacia contributes to lower the glycemix response gum acacia contribute to control blood glucose and insuline levels gum acacia is suitable for diabetics diet gum acacia helps to reduce calorie intake”	Non-authorised	Art.13(1)	EFSA opinion
“Gum acacia contributes to lower the glycemix response gum acacia contribute to control blood glucose and insuline levels gum acacia is suitable for diabetics diet gum acacia helps to reduce calorie intake”	Non-authorised	Art.13(1)	EFSA opinion
“gum acacia helps to reduce blood cholesterol ; gum acacia contribute to maintain a good cardiovascular health ; gum acacia helps to control blood cholesterol level”	Non-authorised	Art.13(1)	EFSA opinion
“gum acacia support renal function ; gum acacia helps renal function during high protein diet ; gum acacia helps to maintain kidney metabolism”	Non-authorised	Art.13(1)	EFSA opinion
“-acacia gum is a bifidogenic fibre; -acacia gum has a prebiotic effect; -acacia gum stimulates the growth of beneficial bacteria in the colon; -acacia gum beneficially modulates the intestinal flora.”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000701

Acacia Longifolia Pollen US-DRUG Not yet graded

US: bla

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000702

Acacia nilotica CA-NHPEU-NOVEL Not yet graded

Not novel in supplementsCA licensed ingredient

also: Babul; Indian gum; Arabic tree; Acacia arabica; Acacia nilotioca (L.) Delile

Market presence32 Canadian licensed products

Parts in scopeBark, fruit and gum

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000703

Acacia Pollen US-DRUG Not yet graded

US: bla

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence18 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000704

Acacia rigidula EU-NOVEL Not yet graded

Novel, not yet authorised

also: Blackbrush Acacia

Parts in scopeWhole

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000705

Acacia verek CA-NHPEU-NOVEL Not yet graded

Not novel in foodCA licensed ingredient

also: Gum acacia; Acacia senegal; Gum Arabic Tree; Gum Senegal Tree; Senegalia senegal (L.) Britton

Market presence9 Canadian licensed products

Parts in scopeGum

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000706

Acai berry CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000707

Acalabrutinib EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: bulk ingredient

Class as recordedKinase Inhibitor [EPC]; L01EL02; Tyrosine Kinase Inhibitors [MoA]

Earliest US approval2017

Market presence12 US product listings · 4 FDA applications · 1 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000708

Acalypha indica CA-NHP Not yet graded

CA licensed ingredient

Market presence13 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000709

Acamprosate US-DRUG Not yet graded

US: anda

Earliest US approval2004

Market presence13 US product listings · 7 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000710

Acanthopanax gracilistylus CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000711

Acanthopanax senticosus CA-NHPEU-HERBEU-NOVEL Not yet graded

Not novel in supplementsHerbal monograph: F: Assessment finalisedCA licensed ingredient

also: Eleutherococcus; Eleutherococci radix; Eleutherococcus senticosus Maxim.

Class as recordedherbal: Fatigue and weakness

Market presence4 Canadian licensed products

Parts in scopeRoots

Recorded fromCA-NHP, EU-HERB, EU-NOVEL — 3 of 7 registers

Etalyn identifierETA-C-000712

Acarbose US-DRUG Not yet graded

US: anda

Class as recordedalpha Glucosidase Inhibitors [MoA]; alpha-Glucosidase Inhibitor [EPC]

Earliest US approval1995

Market presence22 US product listings · 9 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000713

Acca sellowiana EU-NOVEL Not yet graded

Not novel in food

also: Acca sellowiana var. rugosa (Mattos) Mattos

Parts in scopeFruit (berry)

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000714

Acebutolol Hydrochloride US-DRUG Not yet graded

US: anda

Class as recordedAdrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Earliest US approval1984

Market presence12 US product listings · 4 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000715

Aceclidine Hydrochloride US-DRUG Not yet graded

US: bulk ingredient

Class as recordedCholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Earliest US approval2025

Market presence3 US product listings · 1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000716

Acellular Tissue Engineered Vessel US-DRUG Not yet graded

US: bla

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000717

Acepromazine Maleate US-DRUG Not yet graded

US: bulk ingredient

Market presence3 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000718

Acer campestre CA-NHP Not yet graded

CA licensed ingredient

Market presence4 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000719

Acer Campestre Leaf BUD US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000720

Acer Macrophyllum Pollen US-DRUG Not yet graded

US: bla

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000721

Acer Negundo Inner Bark US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000722

Acer Negundo Pollen US-DRUG Not yet graded

US: bla

Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]

Market presence58 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000723

Acer Negundo Root Bark US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000724

Acer Negundo Whole US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000725

Acer Negundo Wood US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000726

Acer nigrum EU-NOVEL Not yet graded

Not novel in food

Parts in scopeSap

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000727

Acer Nigrum Whole US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000728

Acer Pensylvanicum Whole US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000729

Acer Pseudoplatanus Pollen US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000730

Acer rubrum EU-NOVEL Not yet graded

Not novel in food

Parts in scopeSap

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000731

Acer Rubrum Pollen US-DRUG Not yet graded

US: bla

Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]

Market presence43 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000732

Acer Rubrum Whole US-DRUG Not yet graded

US: unapproved homeopathic

Market presence5 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000733

Acer saccharinum CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000734

Acer Saccharinum Pollen US-DRUG Not yet graded

US: bla

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]

Market presence22 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000735

Acer saccharum EU-NOVEL Not yet graded

Not novel in food

also: Acer barbatum f. commune Ashe

Parts in scopeSap

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000736

Acer Saccharum Pollen US-DRUG Not yet graded

US: bla

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]

Market presence69 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000737

Acer Saccharum SAP US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000738

Acerola EU-CLAIMUS-DRUG Not yet graded

EU claims 0 authorised / 2 refusedUS: unapproved homeopathic

Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]

Market presence1 US product listings

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Acerola is a major dietary source of antioxidants Antioxidants from dietary sources contribute to the protection against free radicals which cause cell damage Contributes to the protection of cells and tissues from oxidative damage Help strengthen our bod”	Non-authorised	Art.13(1)	EFSA opinion
“Acerola is a major dietary source of antioxidants/ Antioxidants from dietary sources contribute to the protection against free radicals which cause cell oxidation/ Contributes to the protection of cells and tissues from oxidation/ Help strengthen our body's natural defences against oxidative stress”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000739

Acerola Concentrate CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000740

Acetaldehyde CA-NHPUS-DRUG Not yet graded

CA licensed ingredientUS: unapproved homeopathic

Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]

Market presence23 US product listings · 10 Canadian licensed products

Recorded fromCA-NHP, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000741

Acetaminophen US-DRUG Not yet graded

US: anda

Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Allergens [CS]; Anti-Inflammatory Agents

Earliest US approval1968

Market presence3,857 US product listings · 534 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000742

Acetanilidum CA-NHP Not yet graded

CA licensed ingredient

Market presence7 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000743

Acetazolamide US-DRUG Not yet graded

US: anda

Class as recordedCarbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]

Earliest US approval1953

Market presence85 US product listings · 43 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000745

Acetic Acid CA-NHPUS-DRUG Not yet graded

CA licensed ingredientUS: anda

Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]

Market presence66 US product listings · 21 Canadian licensed products

Recorded fromCA-NHP, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000746

Acetic Acid, (2,4,5-Trichlorophenoxy)-, 2-Ethyl-4-Methylpentyl Ester US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000747

Acetic acid, calcium salt, monohydrate CA-NHP Not yet graded

CA licensed ingredient

Market presence6 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000748

Acetic Acid, Glacial US-DRUG Not yet graded

Earliest US approval1960

Market presence24 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000749

Acetic acid, zinc salt CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000750

Aceticum acidum CA-NHP Not yet graded

CA licensed ingredient

Market presence13 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000751

Acetobacter aceti EU-NOVEL Not yet graded

Not novel in food

Parts in scopeWhole

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000752

Acetohexamide US-DRUG Not yet graded

Earliest US approval1964

Market presence6 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000753

Acetohydroxamic Acid US-DRUG Not yet graded

US: bulk ingredient

Class as recordedUrease Inhibitor [EPC]; Urease Inhibitors [MoA]

Earliest US approval1983

Market presence2 US product listings · 1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000754

Acetone CA-NHPUS-DRUG Not yet graded

CA licensed ingredientUS: bulk ingredient for human prescription compounding

Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Copper [CS]

Market presence15 US product listings · 1 Canadian licensed products

Recorded fromCA-NHP, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000755

Acetophenazine Maleate US-DRUG Not yet graded

Earliest US approval1961

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000756

Acetorphine US-CSA Not yet graded

CSA Schedule Inarcotic

Class as recordedDEA: narcotic / opioid

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000757

Acetrizoate Sodium US-DRUG Not yet graded

Earliest US approval1953

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000758

Acetyl Coenzyme A US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000759

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) US-CSA Not yet graded

CSA Schedule Inarcotic

also: Acetyl Fentanyl -N-phenylacetamide)

Class as recordedDEA: narcotic / opioid

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000760

Acetyl Hexapeptide-8 US-DRUG Not yet graded

US: bulk ingredient

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Market presence6 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000761

Acetyl Hexapeptide-8 Amide US-DRUG Not yet graded

US: bulk ingredient

Class as recordedAscorbic Acid [CS]; Vitamin C [EPC]

Market presence5 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000762

Acetyl L-carnitine EU-NOVEL Not yet graded

Not novel in food

Parts in scopeWhole

Recorded fromEU-NOVEL — 1 of 7 registers

Etalyn identifierETA-C-000763

Acetyl L-Tyrosine US-DRUG Not yet graded

US: bulk ingredient

Class as recordedAmino Acid [EPC]; Amino Acids [CS]

Market presence4 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000764

Acetyl Octapeptide-3 US-DRUG Not yet graded

US: bulk ingredient

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000765

Acetyl Tetrapeptide-5 US-DRUG Not yet graded

US: otc monograph drug

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000766

Acetyl Tetrapeptide-9 US-DRUG Not yet graded

US: otc monograph drug

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000767

Acetyl-alpha-methylfentanyl US-CSA Not yet graded

CSA Schedule Inarcotic

Class as recordedDEA: narcotic / opioid

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000768

acetyl-L-carnitine CA-NHPEU-CLAIM Not yet graded

EU claims 0 authorised / 1 refusedCA licensed ingredient

Market presence5 Canadian licensed products

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“Acetyl-l-carnitine helps to support and maintain healthy brain function.”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromCA-NHP, EU-CLAIM — 2 of 7 registers

Etalyn identifierETA-C-000769

Acetylcarnitine US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Amino Acid [EPC]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000770

Acetylcholine Chloride US-DRUG Not yet graded

US: bulk ingredient

Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Amino Acids

Earliest US approval1973

Market presence19 US product listings · 2 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000771

Acetylcysteine US-DRUG Not yet graded

US: anda

Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antidote [EPC]

Earliest US approval1963

Market presence54 US product listings · 34 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000772

Acetylcysteine Lysine US-DRUG Not yet graded

Earliest US approval2024

Market presence1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000773

Acetyldigitoxin US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]

Market presence1 US product listings · 1 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000774

Acetyldihydrocodeine US-CSA Not yet graded

CSA Schedule Inarcotic

Class as recordedDEA: narcotic / opioid

DEA other namesAcetylcodone

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000775

Acetylmethadol US-CSA Not yet graded

CSA Schedule Inarcotic

Class as recordedDEA: narcotic / opioid

DEA other namesMethadyl acetate

Recorded fromUS-CSA — 1 of 7 registers

Etalyn identifierETA-C-000777

Acetylsalicylic Acid EU-MEDUS-DRUG Not yet graded

EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient

Class as recordedB01AC30

Market presence1 US product listings · 5 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000778

Acetylsalicylicum acidum CA-NHP Not yet graded

CA licensed ingredient

Market presence3 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000779

Achillea alpina CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000780

Achillea Millefolium CA-NHPEU-NOVELUS-DRUG Not yet graded

Not novel in foodCA licensed ingredientUS: drug for further processing

also: Common Yarrow; Achillea millefolium f. pannonica (Scheele) J.Weiss

Class as recordedAllergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]

Market presence58 US product listings · 180 Canadian licensed products

Parts in scopeFlowers and leaves; Other aerial parts and essential oil

Recorded fromCA-NHP, EU-NOVEL, US-DRUG — 3 of 7 registers

Etalyn identifierETA-C-000781

Achillea Millefolium Flower US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]

Market presence17 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000782

Achillea Millefolium Flowering TOP US-DRUG Not yet graded

US: drug for further processing

Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]

Market presence6 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000783

Achillea Millefolium Whole US-DRUG Not yet graded

US: drug for further processing

Class as recordedAllergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]

Market presence32 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000784

Achyranthes aspera CA-NHP Not yet graded

CA licensed ingredient

Market presence25 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000785

Achyranthes bidentata CA-NHP Not yet graded

CA licensed ingredient

Market presence411 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000786

Achyranthes Bidentata Root US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]

Market presence3 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000787

Achyranthes japonica CA-NHP Not yet graded

CA licensed ingredient

Market presence4 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000788

Achyranthes Japonica Root US-DRUG Not yet graded

US: unapproved homeopathic

Market presence1 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000789

Achyranthes longifolia CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000790

Acid casein CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000791

Acid-stable protease CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000792

Acidic water - based, non alcoholic flavoured beverages EU-CLAIM Not yet graded

EU claims 0 authorised / 1 refused

Claims examined by the EU — wording reproduced, not Etalyn’s.

Claim as submitted	Ruling	Basis	Opinion
“poses minimal risk of tooth erosion in relation to tooth erosion, helps keep teeth healthy minimises loss of dental enamel”	Non-authorised	Art.13(1)	EFSA opinion

Recorded fromEU-CLAIM — 1 of 7 registers

Etalyn identifierETA-C-000793

Acidipropionibacterium acidipropionici CA-NHPEU-NOVEL Not yet graded

Not novel in foodCA licensed ingredient

also: Propionibacterium arabinosum; Propionibacterium acidipropionici

Market presence1 Canadian licensed products

Parts in scopeWhole

Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers

Etalyn identifierETA-C-000794

Acidulated Phosphate Fluoride CA-NHP Not yet graded

CA licensed ingredient

Market presence2 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000795

Acidum acetyl salicylicum CA-NHP Not yet graded

CA licensed ingredient

Market presence5 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000796

Acidum arsenicosum CA-NHP Not yet graded

CA licensed ingredient

Market presence23 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000797

Acidum benzoicum e resina CA-NHP Not yet graded

CA licensed ingredient

Market presence9 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000798

Acidum boracicum CA-NHP Not yet graded

CA licensed ingredient

Market presence3 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000799

Acidum carbolicum CA-NHP Not yet graded

CA licensed ingredient

Market presence5 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000800

Acidum chrysophanicum CA-NHP Not yet graded

CA licensed ingredient

Market presence4 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000801

Acidum citricum CA-NHP Not yet graded

CA licensed ingredient

Market presence3 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000802

Acidum formicicum CA-NHP Not yet graded

CA licensed ingredient

Market presence9 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000803

Acidum hydrofluoricum CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000804

Acidum lacticum CA-NHP Not yet graded

CA licensed ingredient

Market presence10 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000805

Acidum nitricum CA-NHP Not yet graded

CA licensed ingredient

Market presence18 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000806

Acidum phosphoricum CA-NHP Not yet graded

CA licensed ingredient

Market presence16 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000807

Acidum picrinicum CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000808

Acidum silicicum CA-NHP Not yet graded

CA licensed ingredient

Market presence4 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000809

Acidum sorbicum CA-NHP Not yet graded

CA licensed ingredient

Market presence3 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000810

Acidum sulfuricum CA-NHP Not yet graded

CA licensed ingredient

Market presence11 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000811

Acipenser huso CA-NHP Not yet graded

CA licensed ingredient

Market presence1 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000812

Acitretin US-DRUG Not yet graded

US: anda

Class as recordedRetinoid [EPC]; Retinoids [CS]

Earliest US approval1996

Market presence41 US product listings · 8 FDA applications

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000813

Aclidinium Bromide EU-MEDUS-DRUG Not yet graded

EU medicine: AuthorisedUS: bulk ingredient

Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; R03AL

Earliest US approval2012

Market presence4 US product listings · 2 FDA applications · 4 EU medicines

Recorded fromEU-MED, US-DRUG — 2 of 7 registers

Etalyn identifierETA-C-000814

Acmella oleracea CA-NHP Not yet graded

CA licensed ingredient

Market presence7 Canadian licensed products

Recorded fromCA-NHP — 1 of 7 registers

Etalyn identifierETA-C-000815

Acmella Oleracea Flowering TOP US-DRUG Not yet graded

US: unapproved homeopathic

Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]

Market presence2 US product listings

Recorded fromUS-DRUG — 1 of 7 registers

Etalyn identifierETA-C-000816